M
REGN icon

Mirova’s Regeneron Pharmaceuticals REGN Stock Holding History

Mirova’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-221
Closed -$213K – 146
2024
Q1 		$213K Hold
221
– – 0.04% 106
2023
Q4 		$194K Sell
221
-11
-5% -$9.06K 0.04% 83
2023
Q3 		$191K Sell
232
-366
-61% -$288K 0.04% 90
2023
Q2 		$430K Sell
598
-623
-51% -$480K 0.08% 97
2023
Q1 		$1M Buy
1,221
+663
+119% +$500K 0.14% 86
2022
Q4 		$403K Sell
558
-583
-51% -$430K 0.06% 121
2022
Q3 		$786K Sell
1,141
-640
-36% -$403K 0.13% 96
2022
Q2 		$1.05M Buy
1,781
+1,104
+163% +$718K 0.15% 85
2022
Q1 		$472K Sell
677
-11
-2% -$6.96K 0.06% 123
2021
Q4 		$434K Sell
688
-1,140
-62% -$701K 0.05% 124
2021
Q3 		$1.11M Buy
1,828
+166
+10% +$103K 0.14% 80
2021
Q2 		$928K Buy
1,662
+100
+6% +$50.7K 0.11% 77
2021
Q1 		$739K Buy
1,562
+216
+16% +$105K 0.09% 89
2020
Q4 		$650K Buy
1,346
+1,281
+1,971% +$691K 0.08% 82
2020
Q3 		$36K Buy
+65
New +$39.4K 0.01% 144

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Mirova's REGN Position: Q2 2024 in Review

Mirova sold out of Regeneron Pharmaceuticals (REGN) in Q2 2024, closing a stake of 221 shares — an estimated $213K sold.

Mirova first reported a position in REGN in Q3 2020 and held it in 15 quarters. The position peaked at $1.11M in Q3 2021. 1,334 funds tracked by Wall St. Rank hold REGN as of Q2 2024.

  • Mirova reported no remaining Regeneron Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Mirova sold 221 Regeneron Pharmaceuticals shares in Q2 2024, an estimated $213K.
  • Mirova first reported a position in Regeneron Pharmaceuticals in Q3 2020 and held it in 15 quarters.
  • Mirova's Regeneron Pharmaceuticals position peaked at $1.11M in Q3 2021.
  • 1,334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2024.

Based on Mirova's 13F filing for Q2 2024, filed 13 Aug 2024.